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1145-27 Is There Still a Role for Physician Assessment in the 
Emergency Department in the Era of Novel Cardiac 
Markers? 
Ali F, Sonel, Jeffrey Whittle, Mary Kelley, Robert L. Wilenskv. University of Pittsburgh and 
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, University of Pennsylvania, 
Philadelphia, Pennsylvania. 
Elevated serum levels troponin I (Tnl), myosin light chain (MLC), and myoglobin (Mb) 
predict short term cardiac ischemic events in patients presenting to the Emergency 
Department (ED) with chest pain. The additive value of such markers with clinical 
assessment has not been assessed. In order to determine the additive predictive value of 
markers of myocardial injury with clinician judgement in predicting early ischemic events 
in patients presenting to the ED, we prospectively studied 247 patients presenting to 2 
EDs within 24 hours of the onset of symptoms consistent with an acute coronary artery 
syndrome. After initial assessment, physicians estimated the probability of a major 
adverse cardiac event (MACE), consisting of death, myocardial infarction or ischemia 
driven revascularization within the initial week based on their initial history, physical 
examination and electrocardiogram (ECG). Serum samples were obtained for Tnl, MLC, 
and Mb at presentation and in 4 hours, Physician decisions were made without the 
knowledge of the cardiac marker results. Mean age of the patient population was 52 ± 13 
years and 54% of subjects were male. During follow-up, 1% died, 13% suffered an acute 
myocardial infarction, and 15% underwent coronary revascutarization. Factors shown to 
predict events included ST-elevation (p<0.00Ol), QRS >120 msec (p=0.005), serial ECG 
changes (p=0.02), pathologic q-waves (p=0.05), an elevated serial Tnl (p=0.006) or 
serial MLC level (p=0.008) and the physician estimate of increased risk (p<0.0001). In 
the multivariable analysis, only ST segment elevation at presentation, a QRS duration 
>120 msec, an elevated MLC and physician prediction of likelihood of cardiac events 
were independent predictors of MACE. A decision rule based solely on physician esti- 
mated probability of MACE and ECG findings had 96% sensitivity and 33% specificity for 
predicting MACE and was not improved by the addition of marker data. Although new 
cardiac markers of myocardial damage provide important information on short-term out- 
come, physician assessment still remains the most important predictor. Hence, use of 
cardiac markers should only be used in conjunction with physician assessment of cardiac 
risk. 
1145-28 Validation of a Simple Electrocardiographic Criterion for 
Early Risk Assessment In Patients With Non-ST 
Segment Elevation Acute Myocardial Infarction 
Jose A. Barrabes, Jaume Figueras, Josefa Cortadellas, Sonia Ibars, Jordi Soler-Soler, 
Hospital Universitad Vail d'Hebren, Barcelona, Spain. 
Background: The prognostic significance of the location of ST segment depression in 
patients with non-ST elevation acute myocardial infarction (AMI) is controversial. We 
aimed to confirm the previous observation that _>0.1 mV ST segment depression in >2 of 
the lateral leads I, aVL, V 5 and V 6 (STD_L) predicts a worse in-hospital outcome. 
Methods; We analyzed 343 consecutive patients admitted to our center between 1996 
and 1999 with a first AMI without Q waves or >0.1 mV ST segment elevation on admis- 
sion. 
Result: STD_L was the only variable from the initial ECG that was related to death after 
adjusting for baseline predictors (odds ratio: 5.3, 95% CI: 1.4 to 20.9, P<0.01), and was 
consistentl 7 associated with other adverse events: 
Event rate (%) No STD STD, non- STD_L 
(n=147) lateral (n=82) (n= 114) 
Death 1.4 1.2 14.9 
Reinfarction 0,7 1.2 11.4 
Angina with ST 10.2 9.8 29.8 
changes 
Severe heart failure 2.0 3.7 32.5 
Patients with STD_L had a similar CK-MB peak than the rest (116±12 vs. 134±10 mcg/I, 
respectively, P=NS). However, among the 176 patients that were catheterized before dis- 
charge, those with STD_L had lower left ventricular ejection fraction (61±2 vs. 68+1%, 
P=0.01) and more frequent left main or three-vessel disease than did the remaining 
patients (56 vs. 23%, P<0.001). Percutaneous intervention was carried out in 24 and 
23% of patients with and without STD_L (P=NS), and surgical revascularization was indi- 
cated in 20 and 7%, respectively (P=0.001). 
Conclusion: In patients with a first non-ST segment elevation acute MI, STDL on 
admission is a simple and efficient criterion for early risk assessment, and its presence is 
related to extensive coronary artery disease. 
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1145-29 Value of Continuous Risk Stratification Early After 
Admlseion in Non-ST-Segment Elevation Acute 
Coronary Syndromes 
Joroe M. Ferraira. Carlos Aguiar, Ana Timdteo, Katya Reis Santos, Ricardo Seabra- 
Gomes, Department of Cardiology, Hospita/ de Santa Cruz, Camaxide, Portugal 
Background: Patients (P) with non-ST-segment elevation acute coronary syndromes 
(ACS) present a wide range of risk of death (D) or (re)-infarction (MI). As a great number 
of these events occur soon during evolution, early risk stratification is imperative. Never- 
theless, after risk stratification at admission, the majority of P fall within a wide grey zone 
of intermediate risk. We sought to identity clinical variables and diagnostic methods pre- 
dictive of D/MI at 30 days, in P classified initially as intermediate risk according to the 
TIMI Risk Score. 
Methods: We studied 254 consecutive P with ACB. TIMI Risk Score was calculated on 
admission, and the sub-groups of P with high and intermediate risk of D/MI at 30 days 
were identified using the best cut-offs for the Score. in the sub-group of intermediate risk, 
we evaluated the prognostic value of clinical variables and diagnostic methods per- 
formed during the first 24 hours and not used in the TIMI Risk Score. 
Results: The incidence of D/MI at 30 days was 93%. A TIMI Risk Score of 6 or 7 (19 P, 
31.6% D/MI) or Score 5 (47 P, 14.9% D/MI) identified only a small group of P at high risk 
for D/MI (p=0.004). The remaining 188 P were classified as intermediate risk: Score 4 (76 
P,  7.9% D/MI), Score 3 (62 P, 4.8% D/MI), Score 2 (35 P, 5.7% D/MI) and Score 0 or 1 
(15 P, 6.7% of D/MI). The presence in the first 24 hours, of signs of heart failure 
(p=0.001), ST-segment shifts > 0.1mV detected by continuous ST-segment monitoring 
(p=0.002) or left ventricular ejection fraction (LVEF)<50% (p=0.012) were predictive of D/ 
MI and identified 92% of these events. The absence of these findings was associated 
with the lowest risk (107 P, 0.9% D/MI) and the risk increased with the number of find- 
ings: 1 finding (53 P, 9.4% D/MI), 2 findings (24 P, 16.7% D/MI) and 3 findings (4 P, 50% 
D/MI). 
Conclusion: Risk stratification at admission using the TIMI Risk Score identified only a 
small group of P at high risk for D/MI at 30 days. In the remaining P at intermediate risk, 
the presence of signs of heart faiiura, ST-segment shifts by continuous ST-segment mon- 
itoring or LVEF<50% identified the majority of those with D/MI. 
1145-30 Abciximab Partially Attenuates Adverse Events 
Associated With Trombocytopenia: Analysis of GUSTO 
IV ACS 
Richard T. Williams. David C. Sane, Lakshmi V. Damaraju, Mary A. Mascelli, Elliot S, 
Barnathan, Robert M. Califf, Maarten Simoons, Wake Forest University/Baptist Medical 
Center, Winston-Salem, North Carolina, Duke Universi~ Durham, North Carolina. 
Background: The development of thrombocytopenia (TCP) in patients with acute coro- 
nary syndromes (ACS) is associated with higher rates of major adverse clinical events 
(MACE) including death, MI and hemorrhage. Although the association between TCP 
and hemorrhage is apparent, the increased risk of MI and death in this group requires 
"further study. The GUSTO IV - ACS trial was designed to assess the effects of abciximab 
on death or MI in non-ST segment elevation ACS patients without early intervention. 
There was no benefit with abciximab use and a trend toward increased MACE with 
longer infusion times in this setting. We hypothesized that prolonged infusions of abcix- 
imab might increase the occurrence of TCP and therefore lead to increased MACE. 
Methods: We examined the occurrence of TCP (platelet count < 100 X 109/L and a 25% 
decrease from baseline) and its effect on MACE in the GUSTO IV - ACS patient popula- 
tion. 
Results: The prevalence of TCP was 1.0 % in the placebo group, 4.7% in the 24 hour 
abciximab infusion group, and 7.0 % in the 48 hour abciximab infusion group (p= 0.001). 
The occurrence of adverse events in the three groups as a function of the presence or 
absence of TCP is tabulated below: 
PLACEBO 24 HR ABCIXIMAB 48 HR ABCIXIMAB 
TCP NOTCP p TCP NOTCP p TCP NOTCP p 
(n=26) (n=2572) (n=121) (n=2469) (n=184) (n=2428) 
Death or MI 26.9% 7.9% 0.003 10.7% 8.1% 0.306 12.5% 8.9% 0.110 
Death, MI or 53.8% 34.8% 0.061 33.1% 33.3% 1.000 35.9% 35.7% 1.000 
Revasc. 
Death 15.4% 3.8% 0.017 4.1% 3.4% 0.604 5.4% 4.2% 0.448 
MI 19.2% 5.0% 0.009 6.6% 5.6% 0.548 9.2% 5.6% 0.050 
Conclusion: TCP is associated with increased MACE in the placebo group, but this 
effect is blunted in the abciximab-treated groups. Although abciximab causes a higher 
rate of TCP, it also lessens the adverse events associated with TCP. The clinical signifi- 
cance and mechanism of these findings warrant further investigation. 
1145-45 Underuse of Evidence-Based Medicine and Outcome of 
Acute Myocardial infarction Patients With Renal Failure 
Ariel Tessone, Israel M. Barbash, Shmuel Gottlieb, Alexander Battler, Yonathan Hasin, 
Valentina Boyko, Avi Porat, Solomon Behar, Jonathan Leor, Neufe/d Cardiac Research 
Institute, TeI-Hashomer, Israel. 
To evaluate the impact of renal failure upon management and outcome of MI patients we 
analyzed data of 1683 consecutive patients with acute MI admitted to 26 hospitals in 
Israel during a 2 month (2-3/2000) peded. We compared clinical characteristics, manage- 
ment and outcome between 132 patients with renal failure (creatinine >1.3 mg/dl) vs. 
1551 without (control) (Table). MI pts with CRF were more likely to die within 30d 
(OR=3.1 ; 95% CI 2.0-4.8 ). After adjustment for age and COomorbidities this association 
declined (OR=1,5; 95% CI 0.9-2.5 ). Adding thrombolysis and PCI into the statistical 
model did not affect the association between CRF and mortality. However, addition of 
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aspirin, beta-blockers and ACE-inhibitors markedly reduced it (OR= 1.1; 95% CI 0.63- 
1.9). Conclusions: MI pts with CRF are older, have more co-morbidities, present with 
higher Killip class and are more likely to experience complications and death. The 
underuse of evidence-based medicine may contribute to poor outcome and needs further 
evaluation. 
Clinical chrectarlstlcs, In-hospital procedures/therapies ,and complications 
Renal Failure No Renal Failure P 
n=132 n=1551 
Age,years (sd) 76 (11) 65 (14) <0.001 
Women 32 (24%) 419 (27%) <0.5 
Hypedension 83 (65%) 707 (46%) <0.001 
Diabetes 55 (43%) 477 (31%) <0.006 
Prior MI 54 (42%) 405 (27%) <0.001 
Kinip>l on 67 (51%) 357 (23%) <0.001 
admission 
Q wave MI 59 (45%) 962 (62%) <0.001 
Thrombolysis 20 (15%) 457 (30%) <0.001 
Coronary angio' 33 (26%) 703 (46%) <0.001 
PCI-in hospital 20 (16%) 434 (29%) <0.002 
Aspirin 106 (84%) 1479 (96%) <0.001 
ACE-inhibitors 49 (51%) 887 (63%) <0.01 
Beta-blockers 53 (54%) 1025 (74%) <0.001 
Heart failure 44 (36%) 308 (21%) <0.001 
Atrial fibrillation 20 (16%) 132 (9%) <0.009 
Sepsis 12 (9%) 42 (3%) <0.001 
Acute renal failure 80 (63%) 97 (6%) <0.001 
1145-46 Chlamydia pneumoniae Infection and Classic Risk 
Factors in the Prediction of Acute Myocardial Infarction 
Kunihire Kinjo, Hiroshi Sate, Hideyuki Sate, Issei Shiotani, Yozo Ohnishi, Daisaku 
Nakatani, Hiroya Mizuno, Eiji Hishida, Yasuhiko Matsu-ura, Yoshiyuki Kijima, Masetsugu 
Hori, Osaka University Graduate School of Medicine, Suita, Japan. 
Background: Several seroepidemiologic studies have shown an association between 
Chlamydia pneumoniae infection and the presence of coronary artery disease (CAD) or 
the risk for acute coronary events. Since it has been suggested that C. pneumoniae 
infection can interact with several classic risk factors of CAD, C. pneumoniae infection 
may enhance the effect of classic risk factors on the onset of AML 
Methods: The case group consisted of 607 patients with AMI. Control group consisted of 
275 subjects without history of definite or suspected coronary heart disease who under- 
went medical examination. Total subjects were tested for specific C. pneumoniae IgG 
and IgA antibodies by ELISA and were also assessed for classic risk factors, i.e., age, 
sex, obesity, diabetes mellitus, hypertension, hyperlipidemia, Iow-HDL cholesterol, and 
smoking habit. Logistic regression model was used to identify an independent predictor 
of the onset of AMI. 
Results: Prevalence of seropositivity for IgA antibody in the case group was significantly 
higher than in the control group (29% vs. 15%; p<0.01), but prevalence of seropositivity 
for IgG antibody was similar in the both groups (17% vs. 16%; p=0.73). In all study popu- 
lations, seropositivity for IgA antibody was not an independent predictor of the onset of 
AMI by multivariate analysis (odds ratio, 1.49; 95% confidence interval, 0.90-2.45). How- 
ever, subgroup analysis revealed that prevalence of seropositivity for IgA antibody was 
an independent predictor of the onset of AMI in patients of <60 years (2.39; 1.11-5.11), 
male patients (1.86; 1.09-3.17), patients with hyperlipidemia (2.42; 1.14-5.12), and smok- 
ers (1.85; 1.02-3.34). 
Conclusion: C. pneumoniae infection enhances the effect of classic risk factors on the 
onset of AMI, especially in patients with hyperlipidemia and in smokers. Thus, measure- 
ment of IgA antibody to C pneumoniae may increase the predictive value of coronary risk 
factors for the onset of AMI. 
1145-47 Ef fect  of Three-Month Antimicrobial Treatment With 
Clarithromycin in Acute Non-Q Wave Coronary 
Syndrome 
Juha P. Sinisalo, Kimmo J. Mattila, Ville Valtonen, Olli Anttonen, Jukka Juvonen, John 
Melin, Helena Vuorinen-Markkola, Markku S. Nieminen, CLARIFY-study group, Helsinki 
University Central Hospital, Helsinki, Finland. 
Background: Coronary artery disease is accepted to be an inflammatory disease and 
infections have been postulated as one of the reasons for this inflammation. We investi- 
gated whether the antibiotic clarithromycin would reduce morbidity and mortality in 
patients presenting with an acute non-Q-wave coronary syndrome. 
Methods: 148 patients with an acute non-Q-wave infarction or unstable angina were ran- 
domly assigned to receive double-blind treatment with either clarithromycin or placebo 
(74 patients in both groups) for 3 months. The primary endpoint was occurrence of the 
composite of death, myocardial infarction, or refractory isehemia during the treatment; 
the secondary endpoint was occurrence of any cardiovascular event during the whole fol- 
low up (average 555 days, range 138 to 924 days). 
Results: There was a trend towards fewer patients meeting the endpoint criteria in the 
clarithromycin group when compared with placebo group (11 vs. 19 patients, respec- 
tively; Cox regression analysis risk ratio 0.54; 95% CI 0.25-1.14; p=0.10) during the 3 
months medication. By the end of the whole follow up period, 16 patients in the clarithro- 
mycin group and 27 patients in the placebo group experienced any cardiovascular event 
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(risk ratio 0.49; 95% CI 0.26-0.92; p=0.03), 
Conclusion: Clarithromycin seems to reduce the risk of ischemic cardiovascular events 
in patients presenting with an acute non-Q-wave infarction or unstable angina. No signs 
of this effect becoming smaller were observed during the follow up. 
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1145-48 Deterioration of Risk Factors Is Not a Major Determinant 
of Coronary Events in Depressive Patients With Acute 
Myocardial Infarction 
Issei Shiotani, Hiroshi Sate, Hideyuki Sate, Kunihiro Kinjo, Daiseku Nakatani, Hiroya 
Mizuno, Eiji Hishida, Yozo Ohnishi, Seiki Nagata, Noritake Houki, Masatsugu Hod, 
Osaka University, Suita, Japan. 
Background: It has been reported that depressive symptoms increase a risk for cardiac 
events and worsen clinical outcomes both in healthy subjects and in patients with acute 
myocardial infarction (AMI). However, mechanisms in which depressive symptoms cause 
coronary events have not been elucidated. The aim of the present study is to test a 
hypothesis that depression deteriorates coronary risk factors and hence increases a risk 
for coronary event in normal subjects and in patients with AMI. Methods: Of consecutive 
1229 patients with AMI were registered to Osaka Acute Coronary Insufficiency Study 
from September 1999 through January 2001, 854 patients who survived and discharged 
from hospital without any clinical disabilities were enrolled in this study (670 men; mean 
age 64±11 y.o). Healthy subjects were selected from outpatient clinic for medical 
checkup (n=1083; 627 men; mean age 49±10 y.o). Depression was assessed using the 
Zung Self-Rating Depression Scale (SDS). Subject with a score of 40 or higher was diag- 
nosed as depression, Results: The SDS score identified depression in 276 healthy sub- 
jects (25.5%) and 361 patients (42.3%) with AMI (p<0.0001). Prevalence of depression 
was associated with women (p=0.071) and young population (p=0,065) in healthy sub- 
jects, however was not associated with other coronary risk factors. Whereas in patients 
with AMI, prevalence of depression was not dependent of age, gender, severity of myo- 
cardial infarction (Killip class, number of disease vessels, peak-CK), and coronary risk 
factors except diabetes meUitus. Multiple logistic regression analyses showed that 
depressive status in patients with AMI was significantly associated with 1-year cardiac 
events (odds ratio 1.45, 96%CI 1.03-2.04, p=0.036), after controlling coronary risk fac- 
tors, e.g. diabetes mellitus, hypertension, hypercholesterolemia, smoking, gout, and obe- 
sity. Conclusion: Depression does not deteriorate coronary risk factors in healthy 
subjects. Furthermore, depression is an independent predictor of 1-year cardiac event 
after controlling risk factors, indicating that deterioration of risk factors may not be a 
major determinant of coronary events in depressive population. 
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1146-31 BNP Identifies Patients With Optimal Reperfusion After 
PTCA for Acute Myocardial Infarction 
Patrick Jourdain, Francois Funck, Michel Be,orini, Nils Guillard, Jean Loiter, Bernard 
Thehault, Michel Desnos, Denis Duboc, H6pital Rene Dubos, Pentoise, France. 
Background : Brain Natriuretic Peptide evaluate the effect of revascularization on (BNP) 
is an hormone synthesized by ventricular myocytes, which has been reported to be 
increased during acute myOCardial infarction (AMI). In order to the level of BNP, we mea- 
sured its concentration in 60 consecutive patients hospitalized for AMI. They were classi- 
fied into Group A : patients in which PTCA restore Timi III flow in the infarct-related artery 
(N = 54), and Group B (N=6) : patients in which no successful PTCA was performed. 
Methods: BNP was measured every 30 minutes during the first 4 hours after admission 
and every 2 hours during the next 12 hours. BNP was measured using the IRMA test (Cis 
Bio laboratories), Reperfusion was performed by angioplasty with direct stenting and was 
effective in all 240 ± 30 minutes after the onset of chest pain. 
Results: in Group A , average BNP measured level fell 30 minutes after restoration of 
TIMI 3 flow in the infarct-related artery. The relative variation of the mean level after 
PTCA was - 58 % ± 16%, p < 0,0001). ~n Group B there was no significant variation of 
BNP. 
Conclusion: Decrease in the level of plasma BNP appears to be a clinically relevant bio- 
logical marker of reperfusion during acute AMI. 
